Detalhe da pesquisa
1.
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Future Oncol
; 17(16): 1987-2003, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682447
2.
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927527
3.
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
BJU Int
; 102(11): 1694-9, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18710444
4.
ETS-TMPRSS2 fusion gene products in prostate cancer.
Cancer Biol Ther
; 5(3): 254-5, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16575200
5.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 33(18): 2004-12, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897158
6.
A phase I study of oral ixabepilone in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 73(5): 1071-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24663504
7.
Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulations.
J Clin Pharmacol
; 53(2): 217-27, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436267
8.
Food increased the bioavailability of BMS-690514, an orally active EGFR/HER2/VEGF receptor kinase inhibitor, in healthy subjects.
J Clin Pharmacol
; 52(9): 1350-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031621
9.
A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors.
Clin Colorectal Cancer
; 6(1): 72-5, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16796796